Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.39 |
| ▸ | HTT | P42858 | 3/20 | 0.39 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 2/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 2/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.35 |
| ▸ | XBP1 | P17861 | 1/20 | 0.35 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL11184747 | 0.97 | ALDH1A1 (0.39) | ALDH1A1NPSR1ALOX15L3MBTL1KMT2A | |
| SCHEMBL22052361 | 0.82 | ALDH1A1 (0.50) | ALDH1A1KMT2AMAPTMEN1TDP1 | |
| SCHEMBL22052359 | 0.76 | MGLL (0.45) | ALDH1A1KMT2AMAPTMEN1KDM4E | |
| SCHEMBL357106 | 0.73 | — | — | |
| SCHEMBL13868489 | 0.73 | — | — | |
| Hydrochloric Acid SCHEMBL11189614 | 0.71 | HTT (0.46) | ALDH1A1NPSR1ALOX15L3MBTL1KMT2A | |
| Hydrochloric Acid SCHEMBL11189609 | 0.71 | HTT (0.46) | ALDH1A1NPSR1ALOX15L3MBTL1KMT2A | |
| SCHEMBL30959 | 0.69 | ALDH1A1 (0.67) | ALDH1A1NPSR1ALOX15L3MBTL1KMT2A | |
| SCHEMBL9490577 | 0.69 | ALDH1A1 (0.67) | ALDH1A1NPSR1ALOX15L3MBTL1KMT2A | |
| SCHEMBL301494 | 0.69 | ALDH1A1 (0.45) | ALDH1A1NPSR1ALOX15L3MBTL1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 60 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2708512-B1 | TIN(II) OXIDE POWDER FOR REPLENISHING TIN COMPONENT OF TIN-ALLOY PLATING SOLUTION AND METHOD FOR MANUFACTURING SAID POWDER | MITSUBISHI MATERIALS CORP (JP) | 2018-09-12 | — | — | EP | claimed |
| CN-103429535-B | For feeding Tin monoxide powder and the autofrettage thereof of Sn composition to Sn alloy electroplating bath | 三菱综合材料株式会社 | 2016-08-17 | — | — | CN | claimed |
| US-9108861-B2 | Tin(II) oxide powder for replenishing tin component of tin-alloy plating solution and method for manufacturing said powder | MITSUBISHI MATERIALS CORPORATION (JP) | 2015-08-18 | — | — | US | claimed |
| US-20140127109-A1 | TIN(II) OXIDE POWDER FOR REPLENISHING TIN COMPONENT OF TIN-ALLOY PLATING SOLUTION AND METHOD FOR MANUFACTURING SAID POWDER | MITSUBISHI MATERIALS CORPORATION (JP) | 2014-05-08 | — | — | US | claimed |
| EP-2708512-A1 | TIN(II) OXIDE POWDER FOR REPLENISHING TIN COMPONENT OF TIN-ALLOY PLATING SOLUTION AND METHOD FOR MANUFACTURING SAID POWDER | Mitsubishi Materials Corporation (JP) | 2014-03-19 | — | — | EP | claimed |
| US-8637703-B2 | Methods for synthesizing ammonia borane | THE OHIO STATE UNIVERSITY (US) | 2014-01-28 | — | — | US | claimed |
| US-4444685-A | Stereospecific synthesis of thienamycin from penicillin | MERCK & CO., INC. (US) | 1984-04-24 | — | — | US | claimed |
| US-20240032422-A1 | LIGHT-EMITTING MATERIAL, COMPOUND, LONG-PERSISTENT PHOSPHOR AND LIGHT-EMITTING ELEMENT | KYULUX, INC. (JP) | 2024-01-25 | — | — | US | disclosed |
| US-20240023437-A1 | ORGANIC ELECTROLUMINESCENCE ELEMENT, AND DESIGN METHOD AND PROGRAM FOR LIGHT EMITTING COMPOSITION | KYULUX, INC. (JP) | 2024-01-18 | — | — | US | disclosed |
| US-11832516-B2 | Light-emitting material, compound, long-persistent phosphor and light-emitting element | KYULUX, INC. (JP) | 2023-11-28 | — | — | US | disclosed |
| US-20230225203-A1 | ORGANIC LUMINESCENT ELEMENT | KYULUX, INC. (JP) | 2023-07-13 | — | — | US | disclosed |
| US-20230209847-A1 | ORGANIC LIGHT EMITTING ELEMENT | KYULUX, INC. (JP) | 2023-06-29 | — | — | US | disclosed |
| US-20230160139-A1 | ELECTROLESS PLATED FIBER MATERIAL, MANUFACTURING METHOD, AND MANUFACTURING SYSTEM THEREFOR | YAMADA CO., LTD. (JP) | 2023-05-25 | — | — | US | disclosed |
| WO-2002102863-A1 | ALPHA-OLEFIN BASED BRANCHED POLYMER | DOW GLOBAL TECHNOLOGIES INC. (US) | 2002-12-27 | — | — | WO | disclosed |
| EP-0404503-A1 | Boron-containing, silicon nitride-based ceramic shaped body production process | Tonen Corporation (JP) | 1990-12-27 | — | — | EP | disclosed |
| EP-0389084-A2 | Process for producing a polyborosilazane | Tonen Corporation (JP) | 1990-09-26 | — | — | EP | disclosed |
| US-4851425-A | Cyclopentapyrazole and tetrahydroindazole compounds and their use as anti-inflammatory and anti-allergic agents | THE UPJOHN COMPANY (US) | 1989-07-25 | — | — | US | disclosed |
| WO-1986007357-A3 | CYCLOPENTAPYRAZOLE AND TETRAHYDROINDAZOLE COMPOUNDS | THE UPJOHN COMPANY (US) | 1987-04-23 | — | — | WO | disclosed |
| US-4525582-A | Silyl, benzyl, p-nitrobenyl, or methyl esters of diazoacetate, a synthon used in the conversion of penicillin to thienamycin | MERCK & CO., INC. (US) | 1985-06-25 | — | — | US | disclosed |
| US-4444685-A | Stereospecific synthesis of thienamycin from penicillin | MERCK & CO., INC. (US) | 1984-04-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240032422-A1 | LIGHT-EMITTING MATERIAL, COMPOUND, LONG-PERSISTENT PHOSPHOR AND LIGHT-EMITTING ELEMENT | NR2E3, CRY1, ESR1 | ALDH1A1 1064/4885NPSR1 795/4885ALOX15 1517/4885 |
| US-11832516-B2 | Light-emitting material, compound, long-persistent phosphor and light-emitting element | NR2E3, CRY1, ESR1 | ALDH1A1 1064/4885NPSR1 795/4885ALOX15 1517/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.